(Q35825344)
Statements
Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension (English)
Michiel J B Kemme
Jeroen P vd Post
Matthias Straub
Adam F Cohen
Joop M A van Gerven
1 reference
1 reference